Jun‐ichi Okano

1.9k total citations
75 papers, 1.5k citations indexed

About

Jun‐ichi Okano is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Jun‐ichi Okano has authored 75 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Hepatology and 14 papers in Surgery. Recurrent topics in Jun‐ichi Okano's work include Liver Disease Diagnosis and Treatment (13 papers), Fish Ecology and Management Studies (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Jun‐ichi Okano is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Fish Ecology and Management Studies (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Jun‐ichi Okano collaborates with scholars based in Japan, United States and Russia. Jun‐ichi Okano's co-authors include Anil K. Rustgi, Yoshikazu Murawaki, Goshi Shiota, Takakazu Nagahara, Kazuya Matsumoto, Hironaka Kawasaki, Toshikazu Nakamura, Morris J. Birnbaum, Hiroshi Nakagawa and Timothy D. Jenkins and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Chemical Physics and Gastroenterology.

In The Last Decade

Jun‐ichi Okano

70 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun‐ichi Okano Japan 20 641 415 329 229 221 75 1.5k
Serene M. L. Lee Germany 22 481 0.8× 173 0.4× 198 0.6× 193 0.8× 155 0.7× 57 1.5k
Yuki Makino Japan 19 389 0.6× 282 0.7× 246 0.7× 166 0.7× 111 0.5× 56 1.0k
Jeffrey M. Macdonald United States 27 1.1k 1.7× 143 0.3× 218 0.7× 211 0.9× 195 0.9× 74 2.5k
Akihiro Mori Japan 19 713 1.1× 120 0.3× 184 0.6× 233 1.0× 297 1.3× 110 1.6k
Giovanni Rizzo Italy 13 394 0.6× 432 1.0× 565 1.7× 585 2.6× 368 1.7× 26 1.8k
Nobukazu Komatsu Japan 27 704 1.1× 120 0.3× 180 0.5× 774 3.4× 182 0.8× 100 1.9k
Ling‐Yu Wang China 23 981 1.5× 182 0.4× 303 0.9× 127 0.6× 97 0.4× 76 1.8k
Jian-Ying Zhang United States 29 1.4k 2.2× 109 0.3× 179 0.5× 466 2.0× 150 0.7× 62 2.8k
Catherine A. Abbott Australia 29 844 1.3× 189 0.5× 292 0.9× 1.6k 6.8× 281 1.3× 74 2.8k

Countries citing papers authored by Jun‐ichi Okano

Since Specialization
Citations

This map shows the geographic impact of Jun‐ichi Okano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐ichi Okano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐ichi Okano more than expected).

Fields of papers citing papers by Jun‐ichi Okano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun‐ichi Okano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐ichi Okano. The network helps show where Jun‐ichi Okano may publish in the future.

Co-authorship network of co-authors of Jun‐ichi Okano

This figure shows the co-authorship network connecting the top 25 collaborators of Jun‐ichi Okano. A scholar is included among the top collaborators of Jun‐ichi Okano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun‐ichi Okano. Jun‐ichi Okano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugihara, Takaaki, Takakazu Nagahara, Kenji Oyama, et al.. (2022). Chronic Active Epstein–Barr Virus Infection Indistinguishable from Autoimmune Hepatitis: A Case Report. Yonago acta medica. 65(2). 160–165. 1 indexed citations
2.
Matono, Tomomitsu, Masahiko Koda, Ken‐ichi Miyoshi, et al.. (2020). Preablation three-dimensional ultrasonography can predict therapeutic effect and local tumor progression after radiofrequency ablation for hepatocellular carcinoma. European Journal of Radiology. 133. 109358–109358. 2 indexed citations
3.
Ishikawa, Naoto F., Yoshito Chikaraishi, Naohiko Ohkouchi, et al.. (2017). Integrated trophic position decreases in more diverse communities of stream food webs. Scientific Reports. 7(1). 2130–2130. 15 indexed citations
4.
Okano, Jun‐ichi, et al.. (2016). The effects of surface roughness of sediment particles on the respiration of case-bearing caddisfly larvae. Freshwater Science. 35(2). 611–618. 5 indexed citations
5.
Koda, Masahiko, Takumi Onoyama, Tomomitsu Matono, et al.. (2016). Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model. World Journal of Hepatology. 8(22). 933–933. 9 indexed citations
6.
Takata, Tomoaki, Masahiko Koda, Takaaki Sugihara, et al.. (2015). Left Renal Cortical Thickness Measured by Ultrasound Can Predict Early Progression of Chronic Kidney Disease. ˜The œNephron journals/Nephron journals. 132(1). 25–32. 29 indexed citations
7.
Koda, Masahiko, Shiho Tokunaga, Jun Kato, et al.. (2015). Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma. Journal of Hepatology. 63(6). 1360–1367. 19 indexed citations
8.
Koda, Masahiko, Satoshi Kuwamoto, Jun‐ya Kato, et al.. (2013). Patient with drug-induced hepatic injury caused by long-term administration of an angiotesin II receptor antagonist, losartan. Kanzo. 54(9). 600–606.
9.
Koda, Masahiko, Jun‐ya Kato, Shiho Tokunaga, et al.. (2011). Drug-induced hepatic injury caused by an aldose reductase inhibitor, epalrestat. Kanzo. 52(6). 351–355. 1 indexed citations
10.
Tokunaga, Shiho, Masahiko Koda, Takakazu Nagahara, et al.. (2011). A case of sepsis due to Edwardsiella tarda with alcoholic liver cirrhosis complicated by hepatocellular carcinoma and lung cancer. Kanzo. 52(2). 120–125. 1 indexed citations
11.
Hosho, Keiko, Jun‐ichi Okano, Masahiko Koda, & Yoshikazu Murawaki. (2008). Vitamin K2 Has No Preventive Effect on Recurrence of Hepatocellular Carcinoma after Effective Treatment. Yonago acta medica. 51(4). 95–99. 7 indexed citations
12.
Okano, Jun‐ichi, Takakazu Nagahara, Kazuya Matsumoto, & Yoshikazu Murawaki. (2008). Caffeine Inhibits the Proliferation of Liver Cancer Cells and Activates the MEK/ERK/EGFR Signalling Pathway. Basic & Clinical Pharmacology & Toxicology. 102(6). 543–551. 77 indexed citations
13.
Okano, Jun‐ichi, Kazuya Matsumoto, Takakazu Nagahara, & Yoshikazu Murawaki. (2006). Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells. Journal of Gastroenterology. 41(2). 166–176. 29 indexed citations
14.
Ueki, Masaru, et al.. (2004). . Kanzo. 45(3). 153–159. 1 indexed citations
15.
Okano, Jun‐ichi, et al.. (2004). . Kanzo. 45(2). 121–124. 1 indexed citations
16.
Ueki, Masaru, et al.. (2003). . Kanzo. 44(9). 448–454.
17.
Okano, Jun‐ichi, et al.. (2003). . Kanzo. 44(2). 66–70. 1 indexed citations
18.
Okano, Jun‐ichi, et al.. (2003). Genetic Alterations in Esophageal Cancer. Humana Press eBooks. 222. 131–145. 25 indexed citations
19.
Okano, Jun‐ichi, Oliver G. Opitz, Hiroshi Nakagawa, et al.. (2000). The Krüppel‐like transcriptional factors Zf9 and GKLF coactivate the human keratin 4 promoter and physically interact. FEBS Letters. 473(1). 95–100. 55 indexed citations
20.
Jenkins, Timothy D., Oliver G. Opitz, Jun‐ichi Okano, & Anil K. Rustgi. (1998). Transactivation of the Human Keratin 4 and Epstein-Barr Virus ED-L2 Promoters by Gut-enriched Krüppel-like Factor. Journal of Biological Chemistry. 273(17). 10747–10754. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serene M. L. Lee Breakdown of academic impact, for papers by Yuki Makino Breakdown of academic impact, for papers by Jeffrey M. Macdonald Breakdown of academic impact, for papers by Akihiro Mori Breakdown of academic impact, for papers by Giovanni Rizzo Breakdown of academic impact, for papers by Nobukazu Komatsu Breakdown of academic impact, for papers by Ling‐Yu Wang Breakdown of academic impact, for papers by Jian-Ying Zhang Breakdown of academic impact, for papers by Catherine A. Abbott
Rankless by CCL
2026